Document Detail

Matrix metalloproteinases as drug targets in acute pulmonary embolism.
MedLine Citation:
PMID:  23316966     Owner:  NLM     Status:  Publisher    
Acute pulmonary embolism is a critical condition associated with increased mortality. Lung embolization causes acute pulmonary hypertension and right ventricle afterload. Global heart ischemia supervenes and may lead to severe shock and death. In this article, we reviewed current literature supporting the idea that abnormal matrix metalloproteinase (MMP) activity contributes to acute pulmonary embolism-induced hemodynamic changes. While low MMP levels are usually found in normal lung tissues, it is well known that inflammation and lung injury increase MMP expression and activity. This is probably due to recruitment and migration of inflammatory cells from the circulation to lung tissues. In addition, recent studies have shown increased MMP levels and activity in the right ventricle from animals with acute pulmonary embolism. Such increases in proteolytic activity were associated with increased cardiac troponin I in serum, suggesting a possible role for MMPs in cardiomyocyte injury during acute pulmonary embolism. These alterations have justified the use of doxycycline as an MMP inhibitor in acute pulmonary embolism. We review current evidence indicating that MMPs are targets in this critical condition. MMP inhibition apparently exerts antihypertensive effects and protects against cardiomyocyte injury caused by acute pulmonary embolism.
Evandro M Neto-Neves; Tamás Kiss; Diána Mühl; Jose E Tanus-Santos
Related Documents :
16501616 - Methods of stem cell delivery in cardiac diseases.
12616356 - Angiographic improvement after rapid intermittent compression treatment [artassist] for...
10996346 - Replication in restenotic atherectomy tissue.
17210076 - Essential thrombocythemia.
15726036 - Cervical artery dissection. a comparison of highly dynamic mechanisms: manipulation ver...
23139486 - Prevalence of periodontal pathogens in coronary atherosclerotic plaque of patients unde...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-07
Journal Detail:
Title:  Current drug targets     Volume:  -     ISSN:  1873-5592     ISO Abbreviation:  Curr Drug Targets     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960531     Medline TA:  Curr Drug Targets     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pharmacology, Faculty of Medicine University of Sao Paulo Av. Bandeirantes, 3900 14049-900 Ribeirao Preto, SP, Brazil.;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-in...
Next Document:  An iTRAQ Proteomic Study Reveals an Association between Diet-induced Enhanced Fatty-acid Metabolism ...